Clinical Trial Update: Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE [NA]

View source ↗

Summary

An early-phase study at MD Anderson uses Bayesian neurobehavioral phenotyping to identify mechanisms of nicotine dependence and tailor personalized neuromodulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Smoking | NA | Status: RECRUITING